These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35045579)

  • 1. Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Rivas A; Lauw MN; Schnabel RB; Crowther M; Van Spall HGC
    Thromb Haemost; 2022 Jun; 122(6):871-878. PubMed ID: 35045579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Shantsila E; Kozieł M; Lip GY
    Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation Therapy and NOACs in Heart Failure.
    Thomas I; EncisoSilva J; Schlueter M; Greenberg B
    Handb Exp Pharmacol; 2017; 243():515-535. PubMed ID: 28233177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials.
    Li W; Seo J; Kokkinidis DG; Palaiodimos L; Nagraj S; Korompoki E; Milionis H; Doehner W; Lip GYH; Ntaios G
    Int J Stroke; 2023 Apr; 18(4):392-399. PubMed ID: 35689348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
    Shantsila E; Lip GY
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial.
    Greenberg B; Neaton JD; Anker SD; Byra WM; Cleland JGF; Deng H; Fu M; La Police DA; Lam CSP; Mehra MR; Nessel CC; Spiro TE; van Veldhuisen DJ; Vanden Boom CM; Zannad F
    JAMA Cardiol; 2019 Jun; 4(6):515-523. PubMed ID: 31017637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
    Mehra MR; Vaduganathan M; Fu M; Ferreira JP; Anker SD; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; Spiro TE; Deng H; Zannad F; Greenberg B
    Eur Heart J; 2019 Nov; 40(44):3593-3602. PubMed ID: 31461239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulants for stroke prevention in heart failure with reduced ejection fraction.
    Schäfer A; Flierl U; Bauersachs J
    Clin Res Cardiol; 2022 Jan; 111(1):1-13. PubMed ID: 34448932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future Direction.
    Lin AY; Dinatolo E; Metra M; Sbolli M; Dasseni N; Butler J; Greenberg BH
    JACC Heart Fail; 2021 Apr; 9(4):243-253. PubMed ID: 33714744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net clinical benefit of antithrombotic therapy in patients with heart failure and sinus rhythm: A network meta-analysis from 5 clinical trials.
    Zhang C; Wang N; Shen NN; Kong LC; He J; Wu Y; Feng D; Gu ZC
    Thromb Res; 2020 Jun; 190():122-128. PubMed ID: 32361051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Heart Failure Type on Thromboembolic and Bleeding Risk in Patients With Atrial Fibrillation on Oral Anticoagulation.
    Mentias A; Briasoulis A; Shantha G; Alvarez P; Vaughan-Sarrazin M
    Am J Cardiol; 2019 May; 123(10):1649-1653. PubMed ID: 30928033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Coagulation Disorders in Heart Failure: From Basic Science to Clinical Perspectives.
    Siniarski A; Gąsecka A; Borovac JA; Papakonstantinou PE; Bongiovanni D; Ehrlinder H; Giustozzi M; Guerreiro RA; Parker WAE
    J Card Fail; 2023 Apr; 29(4):517-526. PubMed ID: 36632933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure: A Comparative Meta-Analysis.
    Reddin C; Judge C; Loughlin E; Murphy R; Costello M; Alvarez A; Ferguson J; Smyth A; Canavan M; O'Donnell MJ
    Stroke; 2021 Oct; 52(10):3151-3162. PubMed ID: 34281383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation in Patients with Heart Failure and Sinus Rhythm.
    Li X; Yang J; Xu D
    Int Heart J; 2020 Nov; 61(6):1204-1211. PubMed ID: 33191346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in heart failure: current status and future direction.
    Gheorghiade M; Vaduganathan M; Fonarow GC; Greene SJ; Greenberg BH; Liu PP; Massie BM; Mehra MR; Metra M; Zannad F; Cleland JG; van Veldhuisen DJ; Shah AN; Butler J
    Heart Fail Rev; 2013 Nov; 18(6):797-813. PubMed ID: 22987320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE-AF registry.
    Contreras JP; Hong KN; Castillo J; Marzec LN; Hsu JC; Cannon CP; Yang S; Maddox TM
    Clin Cardiol; 2019 Mar; 42(3):339-345. PubMed ID: 30582177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
    Siller-Matula JM; Pecen L; Patti G; Lucerna M; Kirchhof P; Lesiak M; Huber K; Verheugt FWA; Lang IM; Renda G; Schnabel RB; Wachter R; Kotecha D; Sellal JM; Rohla M; Ricci F; De Caterina R;
    Int J Cardiol; 2018 Aug; 265():141-147. PubMed ID: 29706429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm.
    Hopper I; Skiba M; Krum H
    Eur J Heart Fail; 2013 Jan; 15(1):69-78. PubMed ID: 23143796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.